| 000 | 01841 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513033409.0 | ||
| 264 | 0 | _c19951206 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0910-5050 | ||
| 024 | 7 |
_a10.1111/j.1349-7006.1995.tb03091.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOhashi, M | |
| 245 | 0 | 0 |
_aInhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism. _h[electronic resource] |
| 260 |
_bJapanese journal of cancer research : Gann _cSep 1995 |
||
| 300 |
_a819-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCDC2-CDC28 Kinases |
| 650 | 0 | 4 |
_aCarcinoma, Lewis Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase 2 |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEllipticines _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 |
_aMicrosomes _xdrug effects |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 | _aPrecipitin Tests |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTopoisomerase II Inhibitors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aSugikawa, E | |
| 700 | 1 | _aNakanishi, N | |
| 773 | 0 |
_tJapanese journal of cancer research : Gann _gvol. 86 _gno. 9 _gp. 819-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1349-7006.1995.tb03091.x _zAvailable from publisher's website |
| 999 |
_c7591397 _d7591397 |
||